Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 697 to 704 of 704 entries
Sorted by: Best Match Show Resources per page
KFP-1, a Novel Calcium-Binding Peptide Isolated from Kefir, Promotes Calcium Influx Through TRPV6 Channels.

Molecular nutrition & food research

Chang GR, Tu MY, Chen YH, Chang KY, Chen CF, Lai JC, Tung YT, Chen HL, Fan HC, Chen CM.
PMID: 34477300
Mol Nutr Food Res. 2021 Nov;65(22):e2100182. doi: 10.1002/mnfr.202100182. Epub 2021 Oct 19.

INTRODUCTION: Kefir is an acidic and alcoholic fermented milk product with multiple health-promoting benefits. A previous study demonstrated that kefir enhanced calcium absorption in intestinal Caco-2 cells. In this study, kefir-fermented peptide-1 (KFP-1) is isolated from the kefir peptide...

Cite
Chang GR, Tu MY, Chen YH, et al. KFP-1, a Novel Calcium-Binding Peptide Isolated from Kefir, Promotes Calcium Influx Through TRPV6 Channels. Mol Nutr Food Res. 2021;65(22):e2100182doi: 10.1002/mnfr.202100182.
Chang, G. R., Tu, M. Y., Chen, Y. H., Chang, K. Y., Chen, C. F., Lai, J. C., Tung, Y. T., Chen, H. L., Fan, H. C., & Chen, C. M. (2021). KFP-1, a Novel Calcium-Binding Peptide Isolated from Kefir, Promotes Calcium Influx Through TRPV6 Channels. Molecular nutrition & food research, 65(22), e2100182. https://doi.org/10.1002/mnfr.202100182
Chang, Gary Ro-Lin, et al. "KFP-1, a Novel Calcium-Binding Peptide Isolated from Kefir, Promotes Calcium Influx Through TRPV6 Channels." Molecular nutrition & food research vol. 65,22 (2021): e2100182. doi: https://doi.org/10.1002/mnfr.202100182
Chang GR, Tu MY, Chen YH, Chang KY, Chen CF, Lai JC, Tung YT, Chen HL, Fan HC, Chen CM. KFP-1, a Novel Calcium-Binding Peptide Isolated from Kefir, Promotes Calcium Influx Through TRPV6 Channels. Mol Nutr Food Res. 2021 Nov;65(22):e2100182. doi: 10.1002/mnfr.202100182. Epub 2021 Oct 19. PMID: 34477300.
Copy Download .nbib Format: NLM
Comparison of Anticoagulation Regimens Following Stent Placement for Nonthrombotic Lower Extremity Venous Disease.

Journal of vascular and interventional radiology : JVIR

Arendt VA, Mabud TS, Kuo WT, Jeon GS, An X, Cohn DM, Fu JX, Hofmann LV.
PMID: 34478851
J Vasc Interv Radiol. 2021 Nov;32(11):1584-1590. doi: 10.1016/j.jvir.2021.08.016. Epub 2021 Aug 31.

PURPOSE: To determine whether subtherapeutic anticoagulation regimens are noninferior to therapeutic anticoagulation regimens following stent placement for nonthrombotic lower extremity venous disease.MATERIALS AND METHODS: Fifty-one consecutive patients (88% women; mean age, 44 years) who underwent stent placement for nonthrombotic...

Cite
Arendt VA, Mabud TS, Kuo WT, et al. Comparison of Anticoagulation Regimens Following Stent Placement for Nonthrombotic Lower Extremity Venous Disease. J Vasc Interv Radiol. 2021;32(11):1584-1590doi: 10.1016/j.jvir.2021.08.016.
Arendt, V. A., Mabud, T. S., Kuo, W. T., Jeon, G. S., An, X., Cohn, D. M., Fu, J. X., & Hofmann, L. V. (2021). Comparison of Anticoagulation Regimens Following Stent Placement for Nonthrombotic Lower Extremity Venous Disease. Journal of vascular and interventional radiology : JVIR, 32(11), 1584-1590. https://doi.org/10.1016/j.jvir.2021.08.016
Arendt, Victoria A, et al. "Comparison of Anticoagulation Regimens Following Stent Placement for Nonthrombotic Lower Extremity Venous Disease." Journal of vascular and interventional radiology : JVIR vol. 32,11 (2021): 1584-1590. doi: https://doi.org/10.1016/j.jvir.2021.08.016
Arendt VA, Mabud TS, Kuo WT, Jeon GS, An X, Cohn DM, Fu JX, Hofmann LV. Comparison of Anticoagulation Regimens Following Stent Placement for Nonthrombotic Lower Extremity Venous Disease. J Vasc Interv Radiol. 2021 Nov;32(11):1584-1590. doi: 10.1016/j.jvir.2021.08.016. Epub 2021 Aug 31. PMID: 34478851.
Copy Download .nbib Format: NLM
Predictive Role of Prior Radiotherapy and Immunotherapy-Related Adverse Effects in Advanced NSCLC Patients Receiving Anti-PD-1/L1 Therapy.

Journal of clinical medicine

Lim JU, Kim SH, Kang HS, Kim SK, Kim JS, Kim JW, Kim SJ, Yeo CD, Choi CM.
PMID: 34442015
J Clin Med. 2021 Aug 21;10(16). doi: 10.3390/jcm10163719.

The present study evaluated the impact of prior radiotherapy (RT) on patients with advanced non-small cell lung cancer (NSCLC) receiving therapy with immune checkpoint inhibitors (ICIs) and further assessed the prognostic factors in patients receiving both RT and ICI....

Cite
Lim JU, Kim SH, Kang HS, et al. Predictive Role of Prior Radiotherapy and Immunotherapy-Related Adverse Effects in Advanced NSCLC Patients Receiving Anti-PD-1/L1 Therapy. J Clin Med. 2021;10(16)doi: 10.3390/jcm10163719.
Lim, J. U., Kim, S. H., Kang, H. S., Kim, S. K., Kim, J. S., Kim, J. W., Kim, S. J., Yeo, C. D., & Choi, C. M. (2021). Predictive Role of Prior Radiotherapy and Immunotherapy-Related Adverse Effects in Advanced NSCLC Patients Receiving Anti-PD-1/L1 Therapy. Journal of clinical medicine, 10(16), . https://doi.org/10.3390/jcm10163719
Lim, Jeong Uk, et al. "Predictive Role of Prior Radiotherapy and Immunotherapy-Related Adverse Effects in Advanced NSCLC Patients Receiving Anti-PD-1/L1 Therapy." Journal of clinical medicine vol. 10,16 (2021). doi: https://doi.org/10.3390/jcm10163719
Lim JU, Kim SH, Kang HS, Kim SK, Kim JS, Kim JW, Kim SJ, Yeo CD, Choi CM. Predictive Role of Prior Radiotherapy and Immunotherapy-Related Adverse Effects in Advanced NSCLC Patients Receiving Anti-PD-1/L1 Therapy. J Clin Med. 2021 Aug 21;10(16). doi: 10.3390/jcm10163719. PMID: 34442015; PMCID: PMC8397093.
Copy Download .nbib Format: NLM
Malignancy in giant cell tumor of bone in the extremities.

Journal of bone oncology

Liu W, Chan CM, Gong L, Bui MM, Han G, Letson GD, Yang Y, Niu X.
PMID: 33251099
J Bone Oncol. 2020 Nov 05;26:100334. doi: 10.1016/j.jbo.2020.100334. eCollection 2021 Feb.

BACKGROUND: Malignancy in giant cell tumor of bone (GCTB) is a rare tumor with relevant literature being sparse. In primary malignant GCTB, distinct areas of benign GCTB are juxtaposed with high-grade sarcoma, while in secondary malignant GCTB sarcoma occurs...

Cite
Liu W, Chan CM, Gong L, et al. Malignancy in giant cell tumor of bone in the extremities. J Bone Oncol. 2020;26:100334doi: 10.1016/j.jbo.2020.100334.
Liu, W., Chan, C. M., Gong, L., Bui, M. M., Han, G., Letson, G. D., Yang, Y., & Niu, X. (2021). Malignancy in giant cell tumor of bone in the extremities. Journal of bone oncology, 26100334. https://doi.org/10.1016/j.jbo.2020.100334
Liu, Weifeng, et al. "Malignancy in giant cell tumor of bone in the extremities." Journal of bone oncology vol. 26 (2021): 100334. doi: https://doi.org/10.1016/j.jbo.2020.100334
Liu W, Chan CM, Gong L, Bui MM, Han G, Letson GD, Yang Y, Niu X. Malignancy in giant cell tumor of bone in the extremities. J Bone Oncol. 2020 Nov 05;26:100334. doi: 10.1016/j.jbo.2020.100334. eCollection 2021 Feb. PMID: 33251099; PMCID: PMC7680773.
Copy Download .nbib Format: NLM
Improving Algorithm for the Alignment of Consecutive, Whole-Slide, Immunohistochemical Section Images.

Journal of pathology informatics

Liang CW, Chang RF, Fang PW, Chen CM.
PMID: 34476109
J Pathol Inform. 2021 Aug 03;12:29. doi: 10.4103/jpi.jpi_106_20. eCollection 2021.

BACKGROUND: Accurate and precise alignment of histopathology tissue sections is a key step for the interpretation of the proteome topology and cell level three-dimensional (3D) reconstruction of diseased tissues. However, the realization of an automated and robust method for...

Cite
Liang CW, Chang RF, Fang PW, et al. Improving Algorithm for the Alignment of Consecutive, Whole-Slide, Immunohistochemical Section Images. J Pathol Inform. 2021;12:29doi: 10.4103/jpi.jpi_106_20.
Liang, C. W., Chang, R. F., Fang, P. W., & Chen, C. M. (2021). Improving Algorithm for the Alignment of Consecutive, Whole-Slide, Immunohistochemical Section Images. Journal of pathology informatics, 1229. https://doi.org/10.4103/jpi.jpi_106_20
Liang, Cher-Wei, et al. "Improving Algorithm for the Alignment of Consecutive, Whole-Slide, Immunohistochemical Section Images." Journal of pathology informatics vol. 12 (2021): 29. doi: https://doi.org/10.4103/jpi.jpi_106_20
Liang CW, Chang RF, Fang PW, Chen CM. Improving Algorithm for the Alignment of Consecutive, Whole-Slide, Immunohistochemical Section Images. J Pathol Inform. 2021 Aug 03;12:29. doi: 10.4103/jpi.jpi_106_20. eCollection 2021. PMID: 34476109; PMCID: PMC8378454.
Copy Download .nbib Format: NLM
OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT.

Retina (Philadelphia, Pa.)

Tan ACS, Jordan-Yu JM, Vyas CH, Gan ATL, Teo KYC, Chan CM, Mathur R, Wong TY, Chakravarthy U, Cheung GCM.
PMID: 34412103
Retina. 2022 Jan 01;42(1):114-122. doi: 10.1097/IAE.0000000000003285.

PURPOSE: To evaluate whether optical coherence tomography (OCT) can determine polypoidal lesion (PL) perfusion in polypoidal choroidal vasculopathy eyes after 12 months of aflibercept monotherapy. Polypoidal lesion perfusion status, assessed by indocyanine green angiography, is an important anatomical outcome...

Cite
Tan ACS, Jordan-Yu JM, Vyas CH, et al. OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT. Retina. 2022;42(1):114-122doi: 10.1097/IAE.0000000000003285.
Tan, A. C. S., Jordan-Yu, J. M., Vyas, C. H., Gan, A. T. L., Teo, K. Y. C., Chan, C. M., Mathur, R., Wong, T. Y., Chakravarthy, U., & Cheung, G. C. M. (2022). OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT. Retina (Philadelphia, Pa.), 42(1), 114-122. https://doi.org/10.1097/IAE.0000000000003285
Tan, Anna C S, et al. "OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT." Retina (Philadelphia, Pa.) vol. 42,1 (2022): 114-122. doi: https://doi.org/10.1097/IAE.0000000000003285
Tan ACS, Jordan-Yu JM, Vyas CH, Gan ATL, Teo KYC, Chan CM, Mathur R, Wong TY, Chakravarthy U, Cheung GCM. OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT. Retina. 2022 Jan 01;42(1):114-122. doi: 10.1097/IAE.0000000000003285. PMID: 34412103.
Copy Download .nbib Format: NLM
GPR120 Inhibits Colitis Through Regulation of CD4.

Gastroenterology

Yang W, Liu H, Xu L, Yu T, Zhao X, Yao S, Zhao Q, Barnes S, Cohn SM, Dann SM, Zhang H, Zuo X, Li Y, Cong Y.
PMID: 34536451
Gastroenterology. 2022 Jan;162(1):150-165. doi: 10.1053/j.gastro.2021.09.018. Epub 2021 Sep 16.

BACKGROUND & AIMS: G protein-coupled receptor (GPR) 120 has been implicated in regulating metabolic syndromes with anti-inflammatory function. However, the role of GPR120 in intestinal inflammation is unknown. Here, we investigated whether and how GPR120 regulates CD4METHODS: Dextran sodium...

Cite
Yang W, Liu H, Xu L, et al. GPR120 Inhibits Colitis Through Regulation of CD4. Gastroenterology. 2021;162(1):150-165doi: 10.1053/j.gastro.2021.09.018.
Yang, W., Liu, H., Xu, L., Yu, T., Zhao, X., Yao, S., Zhao, Q., Barnes, S., Cohn, S. M., Dann, S. M., Zhang, H., Zuo, X., Li, Y., & Cong, Y. (2022). GPR120 Inhibits Colitis Through Regulation of CD4. Gastroenterology, 162(1), 150-165. https://doi.org/10.1053/j.gastro.2021.09.018
Yang, Wenjing, et al. "GPR120 Inhibits Colitis Through Regulation of CD4." Gastroenterology vol. 162,1 (2022): 150-165. doi: https://doi.org/10.1053/j.gastro.2021.09.018
Yang W, Liu H, Xu L, Yu T, Zhao X, Yao S, Zhao Q, Barnes S, Cohn SM, Dann SM, Zhang H, Zuo X, Li Y, Cong Y. GPR120 Inhibits Colitis Through Regulation of CD4. Gastroenterology. 2022 Jan;162(1):150-165. doi: 10.1053/j.gastro.2021.09.018. Epub 2021 Sep 16. PMID: 34536451.
Copy Download .nbib Format: NLM
How can we improve clinical research in clinical practice with better research outcome?.

Woo KT, Wong KS, Lee EJ, Chan CM.
UIID-AD: 2922
2011;40:499-506.

This paper explains some of the difficulties doctors face when taking up a career in research. It describes the efforts by the government and the Ministry of Health (MOH) to nurture the Clinician Scientist Programme. The nature of research...

Cite
Woo KT, Wong KS, Lee EJ, et al. How can we improve clinical research in clinical practice with better research outcome?. 2011;40:499-506
Woo, K. T., Wong, K. S., Lee, E. J., & Chan, C. M. (2011). How can we improve clinical research in clinical practice with better research outcome?. 40499-506.
Woo, K T, et al. "How can we improve clinical research in clinical practice with better research outcome?." vol. 40 (2011): 499-506.
Woo KT, Wong KS, Lee EJ, Chan CM. How can we improve clinical research in clinical practice with better research outcome?. 2011;40:499-506. UIID-AD: 2922.
Copy Download .nbib Format: NLM
Showing 697 to 704 of 704 entries